Hyperandrogenism and Menstrual Imbalance Are the Best Predictors of Metformin Response in PCOS Patients

    January 2022 in “ Reproductive Biology and Endocrinology ”
    Emanuele Garzia, Valentina Galiano, Giovanni Marfia, Stefania Elena Navone, Enzo Grossi, Anna Maria Marconi
    Image of study
    TLDR High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.
    The study involved 108 women with Polycystic Ovary Syndrome (PCOS) treated with 1500 mg/day of metformin. After 6 months, 52.4% of obese patients showed a Body Mass Index (BMI) reduction and 50.6% of hyperandrogenemic women showed a decrease in free-androgen-index (FAI). The response rates at 12 months were 30.6% and 47% respectively. The study concluded that menstrual pattern imbalance and ovarian androgens excess are the best predictors of metformin response. Lower serum testosterone levels at baseline were found to be the major predictor of treatment discontinuation. The study also found that metformin's effects in women with PCOS are not heavily dependent on the presence of insulin resistance. The research also noted a high dropout rate, with 12.9% of women discontinuing treatment due to side effects and 29.6% discontinuing due to perceived ineffectiveness or missed follow-ups.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 7 results

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  38 upvotes 6 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Spironolactine Update: 2 months (34, Female)

      in Female  22 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 1 year ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

    Similar Research

    5 / 1000+ results